Scientific Presentations and Publications
2021 Oncology R&D Day
DOWNLOADWhite Paper
A Simplified Overview of How the Versamune® Platform Overcomes Key Limitations of Immuno-Oncology
DOWNLOAD
Smalley Rumfield C, Pellom ST, Morillon II YM, Schlom J, Jochems C. 2020. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine. J. for ImmunoTherapy of Cancer 8:e000612. |
Vasievich EA, Ramishetti S, Zhang Y, Huang L. 2012. Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model. Mol Pharmaceutics. 9(2): 261-268. |
Vasievich EA, Chen W, Huang L. 2011. Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine. Cancer Immunol Immunother. 60(5): 629-638. |
Chen W, Yan W, Huang L. 2008. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid. Cancer Immunol Immunother. 57(4): 517-530. |
Yan W, Chen W, Huang L. 2007. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Molecular Immunology 44(15): 3672-3681. |
Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD Jr, Huang L. 2006. Immunostimulation of dendritic cell by cationic liposomes. Mol Membr Biol. 23(5): 385-395. |